To further identify the core target of POL in treating NASH, we did the topology analysis of protein–protein interaction and found that IL-6, FOS, PTGS2, and CXCL2 were the top 4 targets of N&P (Figure 5A). This evidence concerns the gene CXCL2 and metabolic dysfunction-associated steatohepatitis.